BioForest

Found 16,611 articles

• FDA Grants Breakthrough Therapy Designation to ADCETRIS® (Brentuximab Vedotin) for Frontline Peripheral T-Cell Lymphomas

  11/15/2018

  - Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to ADCETRIS

• Humana Joins CAQH and the National Effort to Streamline Healthcare Business Practices and Improve Provider Data

  11/14/2018

  CAQH®, an industry alliance working to transform the business of healthcare, today announced that Humana has joined the organization and will serve on the CAQH board of directors.

• Uplevel Enables MSPs to Offer HIPAA-compliant IT Services to Small Business

  11/14/2018

  Network upgrade and targeted marketing help MSPs grow business while saving healthcare firms $3,000 or more

• The Avamere Family of Companies Announces Organizational and Strategic Direction Change

  11/14/2018

  The Avamere Family of Companies announced today a strategic organization change to move from a company of individual entities (Avamere Living, Infinity Rehab and Signature Healthcare At Home) to a cohesive post-acute and community-based health care system.

• Seattle Genetics Initiates Phase 1 Clinical Trial of SEA-BCMA for Patients with Relapsed or Refractory Multiple Myeloma

  11/14/2018

  Seattle Genetics, Inc. (Nasdaq:SGEN) announced today dosing of the first patient in a phase 1 clinical trial evaluating the safety and tolerability of SEA-BCMA for patients with relapsed or refractory multiple myeloma (MM).

• Evolent Health to Participate in Upcoming November 2018 Investor Conference

  11/14/2018

  Evolent Health, Inc. today announced that Chief Executive Officer & Co-Founder Frank Williams and Chief Financial Officer Nicky McGrane will participate in an upcoming investor conference.

• BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences

  11/13/2018

  BioLife Solutions, Inc. today announced that management and scientific personnel will be attending and presenting at the following upcoming events:

• Spokane Doctor Advancing Performance of Total Knee Replacements

  11/13/2018

  New, innovative knee implant designs and surgical techniques made for custom fit total knee replacements.

• Red Cross Issues Urgent Call for Blood Donations Heading into Holiday Season

  11/13/2018

  21,000 fewer blood donations collected during September and October than needed

• Sierra Oncology Reports SRA141 Preclinical Efficacy at EORTC-NCI-AACR Symposium

  11/13/2018

  Novel oral Cdc7 inhibitor, SRA141, demonstrates competitive target selectivity and robust efficacy in several cancer models.

• TeamBest Companies Enters Agreement to Acquire ABT Molecular Imaging, Inc. and Announces Creation of Best ABT, Inc.

  11/12/2018

  Best Medical International, Inc. (BMI) and Best Cyclotron Systems (BCS) both part of the TeamBest group of companies, are pleased to announce the creation of Best ABT, Inc. Best ABT, Inc. has entered into an agreement to acquire ABT Molecular Imaging, Inc. (ABT), a Knoxville, TN based cyclotron manufacturing company.

• Red Cross Helps Thousands of Evacuees Find Safety As Raging California Wildfires Continue to Burn

  11/12/2018

  The American Red Cross is on the ground throughout the State of California, providing shelter, food and comfort for thousands of people forced to leave their homes due to the deadly wildfires burning in both the northern and southern parts of the state.

• Physicians Insurance teams with Milliman Datalytics-Defense to apply machine-learning to claims management strategies

  11/12/2018

  Milliman, Inc., the premier global consulting and actuarial firm, today announced that Physicians Insurance A Mutual Company has selected Milliman Datalytics-Defense® as its advanced analytics legal management platform for processing defense cost invoices.

• New Prevencio Study Using AI Demonstrates Novel Blood Test Accurately Predicts Acute Kidney Injury (AKI) Risk

  11/12/2018

  Prevencio’s multi-protein, AI-driven HART AKI test allows earlier interventions to prevent AKI

• OtoNexus Innovates Using Ultrasound to Help Diagnose Middle Ear Infections

  11/12/2018

  OtoNexus Medical Technologies is developing the world’s first device to help pediatricians instantly and accurately diagnose middle ear infections (Otitis Media) in children and adults.

• First Innovation in Longevity Summit Focuses on Global Investment and Government Regulation

  11/12/2018

  December 10 & 11 event brings together entrepreneurs, investors, the government, media, and NGOs

• Acucela Initiates Phase 3 Study of Emixustat Addressing Patients with Stargardt Disease

  11/11/2018

  Acucela Inc. announced today that on November 7, 2018, the first patient has enrolled (FPFV; first patient first visit) in a study to evaluate Acucela’s leading drug candidate, emixustat hydrochloride (“emixustat”), in subjects with macular atrophy secondary to Stargardt disease.

• CHI Franciscan Hospitals Earn Outstanding Safety Grades

  11/9/2018

   CHI Franciscan hospitals earned top-scoring A and B safety grades according to the fall 2018 Leapfrog Hospital Safety Grades released today by the Leapfrog Group.

• To Address Youth E-Cigarette Epidemic, FDA Must Stop Sales of All Flavored Products and Restrict Marketing and Sales to Protect Kids

  11/9/2018

  FDA Should Also Act Quickly to Ban Menthol Cigarettes

• Teamsters Ratify Agreement With American Red Cross

  11/9/2018

  Wages, Benefits and More Addressed in Three-Year Contract